Log in

PHRM PharmaTher Holdings Ltd CSE · Canada

PharmaTher Holdings (PHRM) news

PharmaTher Holdings Ltd is a public biotech or pharmaceutical company listed on CSE under the ticker PHRM, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest PharmaTher Holdings news

We have not published a story on PharmaTher Holdings yet. When there is news, it will appear here.

Questions about PharmaTher Holdings

What is the ticker symbol of PharmaTher Holdings?

PharmaTher Holdings Ltd trades under the ticker PHRM on CSE.

Where is PharmaTher Holdings listed?

PharmaTher Holdings Ltd is listed on CSE. Our directory also records these other listings: OTC:PHRRF.

Which country or territory is PharmaTher Holdings listed under?

Our directory records PharmaTher Holdings Ltd under Canada.

What does PharmaTher Holdings do?

Our directory classifies PharmaTher Holdings Ltd as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of PharmaTher Holdings?

The ISIN recorded for PharmaTher Holdings Ltd is CA71716H1082.

Does aibio.space cover PharmaTher Holdings?

aibio.space lists PharmaTher Holdings Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to PharmaTher Holdings?

Companies in our directory listed in the same country and business area as PharmaTher Holdings: Waverley Pharma, Nurexone Biologic, HLS Therapeutics, Apotex Health, Helix BioPharma, NervGen Pharma.

Investor discussion: PharmaTher Holdings

Members talk about PharmaTher Holdings (PHRM). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Press releases

Headlines of PharmaTher Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. Newsfile

    PharmaTher Submits Orphan Drug and Rare Pediatric Disease Designation Applications to FDA for 3D-Printed Creatine Monohydrate in GAMT Deficiency

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open CSE:PHRM on TradingView.

Listing details

PharmaTher Holdings Ltd is a public biotech or pharmaceutical company listed on CSE under the ticker PHRM, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
PharmaTher Holdings Ltd
Ticker
PHRM
Listing
CSE
Country or territory
Canada
Business scope
Pharmaceuticals: Major
ISIN
CA71716H1082
Other listed symbols
OTC:PHRRF
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.